A CRM1 Inhibitor Alleviates Cardiac Hypertrophy and Increases the Nuclear Distribution of NT-PGC-1α in NRVMs
Open Access
- 7 May 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 10, 465
Abstract
Chromosomal maintenance 1 (CRM1) inhibitors display antihypertrophic effects and control protein trafficking between the nucleus and the cytoplasm. PGC-1α (peroxisome proliferator-activated receptor gamma coactivator-1alpha) is a type of transcriptional coactivator that predominantly resides in the nucleus and is downregulated during heart failure. NT-PGC-1α is an alternative splicing variant of PGC-1α that is primarily distributed in the cytoplasm. We hypothesized that the use of a CRM1 inhibitor could shuttle NT-PGC-1α into the nucleus and activate PGC-1α target genes to potentially improve cardiac function in a mouse model of myocardial infarction (MI). We showed that PGC-1α and NT-PGC-1α were decreased in MI-induced heart failure mice. Phenylephrine and angiotensin II were applied to induce hypertrophy in neonatal rat ventricular myocytes (NRVMs). The antihypertrophic effects of the CRM1-inhibitor Selinexor was verified through profiling the expression of β-MHC and through visualizing the cell cross-sectional area. NRVMs were transfected with adenovirus-NT-PGC-1α or adenovirus-NLS (nucleus localization sequence)-NT-PGC-1α and then exposed to Selinexor. Confocal microscopy was then used to observe the shuttling of NT-PGC-1α. After NT-PGC-1α was shuttled into the nucleus, there was increased expression of its related genes, including PPAR-α, Tfam, ERR-γ, CPT1b, PDK4, and Nrf2. The effects of Selinexor on post-MI C57BL/6j mice were determined by echocardiography and qPCR. We found that Selinexor showed antihypertrophic effects but did not influence the ejection fraction of MI-mice. Interestingly, the antihypertrophic effects of Selinexor might be independent of NT-PGC-1α transportation.Keywords
This publication has 25 references indexed in Scilit:
- A novel PGC-1α isoform in brain localizes to mitochondria and associates with PINK1 and VDACBiochemical and Biophysical Research Communications, 2013
- PGC-1 Proteins and Heart FailureTrends in Cardiovascular Medicine, 2012
- Localization and Regulation of the N Terminal Splice Variant of PGC-1αin Adult Skeletal Muscle FibersJournal of Biomedicine and Biotechnology, 2012
- The PGC-1 cascade as a therapeutic target for heart failureJournal of Molecular and Cellular Cardiology, 2011
- Regulation of NT-PGC-1α Subcellular Localization and Function by Protein Kinase A-dependent Modulation of Nuclear Export by CRM1Journal of Biological Chemistry, 2010
- Alternative mRNA Splicing Produces a Novel Biologically Active Short Isoform of PGC-1αJournal of Biological Chemistry, 2009
- Suppression of HDAC nuclear export and cardiomyocyte hypertrophy by novel irreversible inhibitors of CRM1Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2009
- Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-γ coactivator 1αProceedings of the National Academy of Sciences, 2006
- The CRM1 Nuclear Export Receptor Controls Pathological Cardiac Gene ExpressionMolecular and Cellular Biology, 2004
- The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation EnzymesMolecular and Cellular Biology, 2000